Breaking News Instant updates and real-time market news.

GLPG

Galapagos NV

$103.79

1.03 (1.00%)

19:48
11/14/18
11/14
19:48
11/14/18
19:48

Galapagos NV initiated with a Strong Buy at Raymond James

Raymond James initiated Galapagos NV with a Strong Buy and $157 price target.

GLPG Galapagos NV
$103.79

1.03 (1.00%)

11/14/18
RAJA
11/14/18
INITIATION
Target $157
RAJA
Strong Buy
Galapagos NV initiated with a Strong Buy at Raymond James
Raymond James analyst Dane Leone initiated Galapagos NV with a Strong Buy rating and $157 price target, stating that lead asset filgotinib could be approved for multiple auto-immune disorders, beginning with U.S. approval for treatment of rheumatoid arthritis during 2020. He forecasts about $2.9B in global filgotinib sales during 2023.
10/30/18
NOMU
10/30/18
NO CHANGE
Target $140
NOMU
Buy
Galapagos price target raised to $140 from $124 at Nomura Instinet
Nomura Instinet analyst Christopher Marai raised his price target for Galapagos NV to $140 following last week's Q3 results and the sale of its partnered-cystic fibrosis program back to AbbVie (ABBV) for $45M upfront and $200M in milestones. The analyst views the upfront payments as upside to expectations and keeps a Buy rating on Galapagos shares.
10/25/18
BMOC
10/25/18
NO CHANGE
Target $192
BMOC
Outperform
Vertex price target lowered to $192 from $204 at BMO Capital
BMO Capital analyst Do Kim lowered his price target on Vertex (VRTX) to $192, saying its in-line Q3 results may be overshadowed by the AbbVie (ABBV) decision to license rights to Galapagos (GLPG) cystic fibrosis program, since the expectation was for the collaboration to dissolve. The analyst adds that while the Galapagos interim data did not make competitive inroads on Vertex therapies, he is still lowering the the FY19 EPS view for the latter to $4.43 from $5.13 on slow ex-U.S. growth amid reimbursement challenges and higher operating expenses. Longer term, Kim keeps his Outperform rating on Vertex.
10/11/18
JEFF
10/11/18
NO CHANGE
Target $210
JEFF
Buy
Jefferies sees shares of Vertex 'going back up and recovering'
Shares of Vertex Pharmaceuticals (VRTX) have pulled back from recent highs of $190-$195 down to $175 on "risk-off rotation" amid the broader market selloff, Jefferies analyst Michael Yee tells investors in a research note. However, nothing fundamental has happened and Vertex still has the "cleanest growth story in large biotech," Yee contends. The triple pill has confirmed Phase III pivotal data coming Q4 and upcoming competitor Galapagos NV (GLPG) data "probably will eventually disappoint," claims the analyst. He also views CTX001 coming off clinical hold as a "nice positive" and thinks the company's pipeline is likely to start garnering more focus over the next 6-12 months. Yee sees the stock "eventually going back up and recovering" and keeps a Buy rating on Vertex with a $210 price target.

TODAY'S FREE FLY STORIES

10:25
12/19/18
12/19
10:25
12/19/18
10:25
General news
Treasury Action: flattening is the trade ahead of the FOMC »

Treasury Action:…

10:25
12/19/18
12/19
10:25
12/19/18
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

10:25
12/19/18
12/19
10:25
12/19/18
10:25
Conference/Events
UBS retail analyst to hold an analyst/industry conference call »

Retail Analyst Sole…

10:20
12/19/18
12/19
10:20
12/19/18
10:20
General news
FX Action: The dollar »

FX Action: The dollar…

SPY

SPDR S&P 500 ETF Trust

$257.02

1.93 (0.76%)

10:20
12/19/18
12/19
10:20
12/19/18
10:20
Options
Size ratio spread in SPYders weekly options »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
12/19/18
12/19
10:20
12/19/18
10:20
General news
Treasury Action: yields remained pinned lower »

Treasury Action: yields…

ULTA

Ulta Beauty

$245.00

4.07 (1.69%)

, MTCH

Match Group

$42.58

0.6 (1.43%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ULTA

Ulta Beauty

$245.00

4.07 (1.69%)

MTCH

Match Group

$42.58

0.6 (1.43%)

SSTI

ShotSpotter

$30.30

1.12 (3.84%)

OKTA

Okta

$66.09

3.32 (5.29%)

CLLS

Cellectis

$18.35

0.6 (3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 09

    Jan

  • 16

    Jan

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

, ADI

Analog Devices

$87.50

-0.57 (-0.65%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

ADI

Analog Devices

$87.50

-0.57 (-0.65%)

UAA

Under Armour

$18.63

-0.18 (-0.96%)

UA

Under Armour

$17.21

-0.18 (-1.04%)

MU

Micron

$33.30

-0.82 (-2.40%)

JPM

JPMorgan

$99.31

0.79 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 08

    Jan

  • 08

    Jan

  • 31

    Jan

  • 26

    Feb

  • 03

    Mar

MDT

Medtronic

$92.20

0.18 (0.20%)

, MASI

Masimo

$106.37

1.08 (1.03%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

MDT

Medtronic

$92.20

0.18 (0.20%)

MASI

Masimo

$106.37

1.08 (1.03%)

DRI

Darden

$103.74

-0.08 (-0.08%)

BBY

Best Buy

$52.56

0.57 (1.10%)

GE

General Electric

$7.78

0.505 (6.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/19/18
12/19
10:17
12/19/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/19/18
12/19
10:16
12/19/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/19/18
12/19
10:15
12/19/18
10:15
General news
U.S. existing home sales rose 1.9% to 5.320 M in November »

U.S. existing home sales…

10:15
12/19/18
12/19
10:15
12/19/18
10:15
General news
Breaking General news story  »

Week of 12/14 EIA…

XLU

Utilities SPDR

$54.42

-0.21 (-0.38%)

10:10
12/19/18
12/19
10:10
12/19/18
10:10
Options
18.8K SPDR Utility Fund Dec 51 - 53 put spreads trade 12c »

18.8K SPDR Utility Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FND

Floor & Decor

$26.63

0.09 (0.34%)

10:06
12/19/18
12/19
10:06
12/19/18
10:06
Recommendations
Floor & Decor analyst commentary  »

Morgan Stanley says Floor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$35.14

0.73 (2.12%)

10:05
12/19/18
12/19
10:05
12/19/18
10:05
Hot Stocks
BorgWarner extends agreement to be Official Turbocharger Partner of INDYCAR »

BorgWarner and INDYCAR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEED

Origin Agritech

$6.37

(0.00%)

10:03
12/19/18
12/19
10:03
12/19/18
10:03
Hot Stocks
Origin Agritech announces establishment of two additional joint ventures »

Origin Agritech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
12/19/18
12/19
10:02
12/19/18
10:02
General news
Existing Home Sales data reported »

November Existing Home…

APD

Air Products

$156.68

1.95 (1.26%)

10:02
12/19/18
12/19
10:02
12/19/18
10:02
Hot Stocks
Air Products to supply three nitrogen generation plants to energy project »

Air Products and N.V.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$169.62

-15.39 (-8.32%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
FedEx falls -8.4% »

FedEx is down -8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSI

FTS International

$7.54

-0.7 (-8.50%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
FTS International falls -8.6% »

FTS International is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

UGAZ

VelocityShares 3x Long Natural Gas ETN

$73.20

-14.04 (-16.09%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -15.9% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil

$24.37

2.16 (9.73%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
Jabil rises 9.8% »

Jabil is up 9.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$169.62

-15.39 (-8.32%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Options
Fedex delivers pain to pre-earnings call buyers »

Fedex delivers pain to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIVI

Civitas Solutions

$17.60

1.91 (12.17%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
Civitas Solutions rises 12.5% »

Civitas Solutions is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.